Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
来源:
Nasdaq GlobeNewswire
/
28 11月 2023 06:59:00 America/New_York
N/A
分享